Key result
Transgenic HCM mice display chamber-specific lymphatic alterations, including a ~2.2-fold increase in enlarged right atrial vessels.
Why the study?
3D microscopy and quantitative image analysis methods are needed to study cardiac lymphatic vessel morphology and pathological remodeling in mouse hearts with familial hypertrophic cardiomyopathy.
A novel 3D lightsheet microscopy workflow enables detailed quantitative analysis of pathological remodeling in cardiac lymphatic vessels in a mouse model of hypertrophic cardiomyopathy.
Lymphatic remodeling in HCM mice does not yet inform clinical care; leaves open whether similar changes occur and matter in patients.
Objective 3D microscopy and image data analysis are necessary for studying the morphology of cardiac lymphatic vessels (LyVs) and association with other cell types. We aimed to develop a methodology for 3D multiplexed lightsheet microscopy and highly sensitive and quantitative image analysis to identify pathological remodeling in the 3D morphology of LyVs in young adult mouse hearts with familial hypertrophic cardiomyopathy (HCM). Methods We developed a 3D lightsheet microscopy workflow providing a quick turn-around (as few as 5-6 days), multiplex fluorescence detection, and preservation of LyV structure and epitope markers. Hearts from non-transgenic (NTG) and transgenic (TG) HCM mice were arrested in diastole, retrograde perfused, immunolabeled, optically cleared, and imaged. We built an image processing pipeline to quantify LyV morphological parameters at the chamber and branch levels. Results Chamber-specific pathological alterations of LyVs were identified, but most significantly in the right atrium (RA). TG hearts had a higher volume fraction of ER-TR7 + fibroblasts and reticular fibers. In the RA, we found associations between ER-TR7 + volume fraction and both LyV segment density and median diameter. Conclusions This workflow and study enabled multi-scale analysis of pathological changes in cardiac LyVs of young adult mice, inviting ideas for research on LyVs in cardiac disease.
No takes yet. Share an insight, caveat, or question.
Phillips et al. (2023) studied Familial hypertrophic cardiomyopathy (HCM). Transgenic HCM model (Tm-E180G mutation) vs. Non-transgenic (NTG) mice was evaluated on Morphological parameters of cardiac lymphatic vessels (LyVs) and ER-TR7+ volume fraction. Transgenic hypertrophic cardiomyopathy mice exhibited chamber-specific pathological alterations of lymphatic vessels, including a 2.2-fold increase in vessels wider than 14 µm in the right atrium.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: